Bio-Rad Laboratories BIO Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation at other companies
Other financials
Where this comes from
Reported directly by Bio-Rad Laboratories in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Rad Laboratories's cash provided by (used in) financing activity, including discontinued operation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Rad Laboratories's cash provided by (used in) financing activity, including discontinued operation?
- Bio-Rad Laboratories (BIO) reported cash provided by (used in) financing activity, including discontinued operation of -$44M in Q1 2026.
- How has Bio-Rad Laboratories's cash provided by (used in) financing activity, including discontinued operation changed year-over-year?
- Bio-Rad Laboratories's cash provided by (used in) financing activity, including discontinued operation increased by 55.0% year-over-year, from -$97.7M to -$44M.
- What is the long-term trend for Bio-Rad Laboratories's cash provided by (used in) financing activity, including discontinued operation?
- Over 2 years (2023 to 2025), Bio-Rad Laboratories's cash provided by (used in) financing activity, including discontinued operation has grown at a -18.0% compound annual growth rate (CAGR), from -$425.6M to -$286.5M.
- What does cash provided by (used in) financing activity, including discontinued operation mean?
- This metric measures the net cash flow between the company and its capital providers, including proceeds from debt or equity issuance and payments for dividends or share repurchases. It highlights how the company finances its operations and returns value to shareholders.